-transparent.png){kind=logo}
Sera from 203 recipients prior to transplantation were examined against a panel of 30 T and B lymphocytes at 5 degrees C and 37 degrees C. Those patients classified as having B-cold cytotoxins only had higher 1-year transplant survival rates from cadaver donors (82%) than patients with no antibodies (58%) or patients with antibodies reactive to T and B lymphocytes in the warm (37%). These results based on transplants from a single center confirm earlier studies derived from patients in 27 centers.
Related Publications
Y Iwaki, and
P I Terasaki, and
R Weil, and
L Koep, and
T Starzl
September 1985,
Transplantation,
Y Iwaki, and
P I Terasaki, and
R Weil, and
L Koep, and
T Starzl
August 1977,
Vox sanguinis,
Y Iwaki, and
P I Terasaki, and
R Weil, and
L Koep, and
T Starzl
January 1988,
Clinical transplants,
Y Iwaki, and
P I Terasaki, and
R Weil, and
L Koep, and
T Starzl
December 1979,
Transplantation proceedings,
Y Iwaki, and
P I Terasaki, and
R Weil, and
L Koep, and
T Starzl
February 1991,
Transplantation proceedings,
Y Iwaki, and
P I Terasaki, and
R Weil, and
L Koep, and
T Starzl
January 1974,
Tissue antigens,
Y Iwaki, and
P I Terasaki, and
R Weil, and
L Koep, and
T Starzl
September 2016,
Transplant international : official journal of the European Society for Organ Transplantation,
Y Iwaki, and
P I Terasaki, and
R Weil, and
L Koep, and
T Starzl
June 1976,
Lancet (London, England),
Y Iwaki, and
P I Terasaki, and
R Weil, and
L Koep, and
T Starzl
June 2021,
World journal of transplantation,
Y Iwaki, and
P I Terasaki, and
R Weil, and
L Koep, and
T Starzl
January 2015,
Annals of hepatology,
